Lv5
1450 积分 2024-09-13 加入
Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial
1个月前
已完结
Advances in fluorescent probes for targeting organelles: Design strategies, applications and perspectives
2个月前
已完结
An overview on recent advances of reversible fluorescent probes and their biological applications
2个月前
已完结
Could GLP-1 Receptor Agonists Like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions?
2个月前
已完结
Semaglutide for weight loss in obese patients as an adjunctive treatment for hidradenitis suppurativa: its impact on disease control and quality of life
2个月前
已完结
Obesity in Hidradenitis Suppurativa: Are GLP-1 Receptor Agonists the New Frontier?
2个月前
已关闭
Long-Acting, Longer-Acting, and Ultralong-Acting Antiobesity Peptides
2个月前
已完结
Glucagon‐like peptide‐1 analogue therapy for psoriasis patients with obesity and type 2 diabetes: a prospective cohort study
4个月前
已完结
Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement
4个月前
已完结
656-P: Antifibrotic Potential of a Novel Long-Acting Glucagon/GIP/GLP-1 Triple Agonist (HM15211) in Preclinical Models of Fibrosis
4个月前
已关闭
皖公网安备34019202002308
